Cargando…

An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

Please cite this paper as: Talaat et al. (2012) An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750‐2659.2012.00350.x. Background Live attenuated influenza vaccines (LAIV) against a variety of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talaat, Kawsar R., Karron, Ruth A., Liang, Philana H., McMahon, Bridget A., Luke, Catherine J., Thumar, Bhagvanji, Chen, Grace L., Min, Ji‐Young, Lamirande, Elaine W., Jin, Hong, Coelingh, Kathy L., Kemble, George W., Subbarao, Kanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527634/ https://www.ncbi.nlm.nih.gov/pubmed/22417012 http://dx.doi.org/10.1111/j.1750-2659.2012.00350.x

Ejemplares similares

Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children
por: Karron, Ruth A., et al.
Publicado: (2012)

Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination
por: Peng, YanChun, et al.
Publicado: (2015)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens
por: Driscoll, Amanda J., et al.
Publicado: (2014)

386. Participant Reflections on Their Experiences Participating in Phase 1 and 2 Inpatient Vaccine Trials and Human Challenge Studies
por: Wunderlich, Bettina, et al.
Publicado: (2023)

Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated
por: Cunningham, Coleen K, et al.
Publicado: (2019)

Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines
por: Sutton, Troy C., et al.
Publicado: (2017)

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
por: Bukreyev, Alexander, et al.
Publicado: (2004)

In Vivo Imaging of Influenza Virus Infection in Immunized Mice
por: Czakó, Rita, et al.
Publicado: (2017)

Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus
por: Lakdawala, Seema S., et al.
Publicado: (2011)

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
por: Houser, Katherine V., et al.
Publicado: (2016)

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
por: Vogel, Leatrice N., et al.
Publicado: (2007)

Influenza A Virus Assembly Intermediates Fuse in the Cytoplasm
por: Lakdawala, Seema S., et al.
Publicado: (2014)

Correction: Influenza A Virus Assembly Intermediates Fuse in the Cytoplasm
por: Lakdawala, Seema S., et al.
Publicado: (2016)

H5N1 Vaccine-Specific B Cell Responses in Ferrets Primed with Live Attenuated Seasonal Influenza Vaccines
por: Cheng, Xing, et al.
Publicado: (2009)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
por: Suguitan, Amorsolo L, et al.
Publicado: (2006)

Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in Humans
por: Sutton, Troy C., et al.
Publicado: (2022)

Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
por: Houser, Katherine V., et al.
Publicado: (2017)

SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
por: Frieman, Matthew B., et al.
Publicado: (2010)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

SARS-CoV-2: A New Song Recalls an Old Melody
por: Subbarao, Kanta
Publicado: (2020)

H5N1 Viruses and Vaccines
por: Subbarao, Kanta, et al.
Publicado: (2007)

Vaccines for Pandemic Influenza
por: Luke, Catherine J., et al.
Publicado: (2006)

The Role of Animal Models In Influenza Vaccine Research
por: Luke, Catherine J., et al.
Publicado: (2010)

The role of animal models in influenza vaccine research
por: Luke, Catherine J., et al.
Publicado: (2008)

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
por: Ambrose, Christopher S., et al.
Publicado: (2008)

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro
por: Kam, Yiu Wing, et al.
Publicado: (2007)

Prevalence and Credibility of Nutrition and Health Claims: Policy Implications from a Case Study of Mongolian Food Labels
por: Chimedtseren, Nyamragchaa, et al.
Publicado: (2020)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

The Critical Interspecies Transmission Barrier at the Animal–Human Interface
por: Subbarao, Kanta
Publicado: (2019)

Editorial: Immunological aspects of vaccine safety
por: Vajdy, Michael, et al.
Publicado: (2023)

Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
por: Clarkson, Kristen A., et al.
Publicado: (2021)

No Clinical Association of Live Attenuated Influenza Virus with Nasal Carriage of Bacteria or Acute Otitis Media
por: Coelingh, Kathleen L., et al.
Publicado: (2014)

Scientific barriers to developing vaccines against avian influenza viruses
por: Subbarao, Kanta, et al.
Publicado: (2007)

Animal Models for Sars
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Is there an ideal animal model for SARS?
por: Subbarao, Kanta, et al.
Publicado: (2006)

Respiratory Virus Infections: Understanding COVID-19
por: Subbarao, Kanta, et al.
Publicado: (2020)

Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches
por: Parmar, Meet, et al.
Publicado: (2022)

The soft palate is an important site of adaptation for transmissible influenza viruses
por: Lakdawala, Seema S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tki73o40iil7s4t0ua9757nnqd